Achieving a dominant Rare Neurodegenerative Diseases Treatment Market Share is a unique and high-stakes commercial objective, heavily reliant on securing and defending intellectual property for breakthrough treatments. Market leadership is often concentrated among biotechnology firms that successfully develop and bring to market the first disease-modifying therapy for a specific rare condition....